$0.2010
-0.15-42.59%
At close: Nov 13, 4:00 PM EST
Oragenics Inc (OGEN) Stock Price, Quote, News & History
OGENAMEX
Oragenics completed a key study showing its nasal spray drug ONP-002 effectively targets brain-related nasal areas, setting the stage for Phase 2 trials in...
You can purchase shares of Oragenics (AMEX:OGEN) through any online brokerage.
Other companies in Oragenics’s space includes: AbbVie Inc (NYSE:ABBV), Amgen Inc (NASDAQ:AMGN), Gilead Sciences Inc (NASDAQ:GILD), Vertex Pharmaceuticals Inc (NASDAQ:VRTX) and Regeneron Pharmaceuticals Inc (NASDAQ:REGN).
There is no analysis for Oragenics to provide a consensus price target.
The stock price for Oragenics (AMEX: OGEN) is $ last updated .
There are no upcoming dividends for Oragenics.
Oragenics does not have any upcoming earnings scheduled.
There is no upcoming split for Oragenics.
Oragenics is in the Health Care sector and Biotechnology industry. They are listed on the AMEX.
Oragenics Inc is a development-stage biopharmaceutical company dedicated to the research and development of nasal delivery pharmaceutical therapies targeting neurological conditions and infectious diseases. The Company is currently focused on...
